Monoclonal antibody treatments were used less among Black, Asian, Hispanic and other race COVID-19 patients when compared to white and non-Hispanic COVID-19 patients, according to a data analysis published Jan. 21 by the CDC.
Category: Public Health
Patient, Beware: Some States Still Pushing Ineffective Covid Antibody Treatments
The top 12 states using antibody therapies produced by Regeneron and Lilly — which research shows don’t work against the omicron variant — include several Southern states with some of the nation’s lowest vaccination rates, but also California, which ranks among the top 20 for fully vaccinated residents.